Use of phanquinone for the treatment or prevention of memory impairment
AssigneePrana Biotechnology Limited
InventorsMichel Xilinas, Panayotis Nikolas Gerolymatos
Life of this patent
Estimating the term…
Abstract
The use of phanquinone (4,7-phenanthroline-5,6-dione) for the treatment or prevention of memory impairment is suggested. Also a method for improving the learning or memory of a normal subject is suggested, said method comprising the administering of phanquinone, optionally together with one or more pharmaceutically acceptable carrier(s).
Claims11
A method of treating a subject suffering from memory impairment, comprising administering to the subject an amount of phanquinone effective to treat the memory impairment, provided that the memory impairment is not caused by Alzheimer's disease.
A method of treating a subject suffering from memory impairment, comprising administering to the subject an amount of phanquinone effective to improve learning or memory, provided that the memory impairment is not caused by Alzheimer's disease.
Dependencies are inferred from the claim text.